| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Economic Evaluation of Two Ototopical Treatments for Acute Otitis Media in Tympanostomy Tube Patients
|
Roland, Peter S.
|
|
2006
|
9 |
4 |
p. 219-226
8 p.
|
artikel
|
| 2 |
An Economic Evaluation of Two Ototopical Treatments for Acute Otitis Media in Tympanostomy Tube Patients
|
Roland, Peter S.
|
|
2006
|
9 |
4 |
p. 219-226
|
artikel
|
| 3 |
Applying the Grid Computation in Long-Term Retrospective Health Insurance Data Analysis
|
|
|
2006
|
9 |
4 |
p. 275-
1 p.
|
artikel
|
| 4 |
Applying the Grid Computation in Long-Term Retrospective Health Insurance Data Analysis
|
|
|
2006
|
9 |
4 |
p. 275
|
artikel
|
| 5 |
Are Australians Able to Access New Medicines on the Pharmaceutical Benefits Scheme in a More or Less Timely Manner? An Analysis of Pharmaceutical Benefits Advisory Committee Recommendations, 1999–2003
|
Wonder, Michael J.
|
|
2006
|
9 |
4 |
p. 205-212
8 p.
|
artikel
|
| 6 |
Are Australians Able to Access New Medicines on the Pharmaceutical Benefits Scheme in a More or Less Timely Manner? An Analysis of Pharmaceutical Benefits Advisory Committee Recommendations, 1999–2003
|
Wonder, Michael J.
|
|
2006
|
9 |
4 |
p. 205-212
|
artikel
|
| 7 |
Comparing the EQ-5D and the SF-6D Descriptive Systems to Assess Their Ceiling Effects in the US General Population
|
Bharmal, Murtuza
|
|
2006
|
9 |
4 |
p. 262-271
10 p.
|
artikel
|
| 8 |
Comparing the EQ-5D and the SF-6D Descriptive Systems to Assess Their Ceiling Effects in the US General Population
|
Bharmal, Murtuza
|
|
2006
|
9 |
4 |
p. 262-271
|
artikel
|
| 9 |
Estimating the Cost-Effectiveness of Fluticasone Propionate for Treating Chronic Obstructive Pulmonary Disease in the Presence of Missing Data
|
Briggs, Andrew H.
|
|
2006
|
9 |
4 |
p. 227-235
9 p.
|
artikel
|
| 10 |
Estimating the Cost-Effectiveness of Fluticasone Propionate for Treating Chronic Obstructive Pulmonary Disease in the Presence of Missing Data
|
Briggs, Andrew H.
|
|
2006
|
9 |
4 |
p. 227-235
|
artikel
|
| 11 |
Formulary Decision-Making Should Rely on the Best Available Evidence
|
|
|
2006
|
9 |
4 |
p. 277-279
3 p.
|
artikel
|
| 12 |
Formulary Decision-Making Should Rely on the Best Available Evidence
|
|
|
2006
|
9 |
4 |
p. 277-279
|
artikel
|
| 13 |
Fraction of Nursing Home Admissions Attributable to Urinary Incontinence
|
Morrison, Alan
|
|
2006
|
9 |
4 |
p. 272-274
3 p.
|
artikel
|
| 14 |
Fraction of Nursing Home Admissions Attributable to Urinary Incontinence
|
Morrison, Alan
|
|
2006
|
9 |
4 |
p. 272-274
|
artikel
|
| 15 |
Indirect Costs and Cost-Effectiveness Analysis
|
Ernst, Richard
|
|
2006
|
9 |
4 |
p. 253-261
9 p.
|
artikel
|
| 16 |
Indirect Costs and Cost-Effectiveness Analysis
|
Ernst, Richard
|
|
2006
|
9 |
4 |
p. 253-261
|
artikel
|
| 17 |
Is Rosuvastatin Really a More Efficient Therapeutic Option than Atorvastatin?
|
|
|
2006
|
9 |
4 |
p. 276-277
2 p.
|
artikel
|
| 18 |
Is Rosuvastatin Really a More Efficient Therapeutic Option than Atorvastatin?
|
|
|
2006
|
9 |
4 |
p. 276-277
|
artikel
|
| 19 |
Managing Meningococcal Disease in the United States: Hospital Case Characteristics and Costs by Age
|
O'Brien, Judith A.
|
|
2006
|
9 |
4 |
p. 236-243
8 p.
|
artikel
|
| 20 |
Managing Meningococcal Disease in the United States: Hospital Case Characteristics and Costs by Age
|
O’Brien, Judith A.
|
|
2006
|
9 |
4 |
p. 236-243
|
artikel
|
| 21 |
Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?
|
Griffin, Susan
|
|
2006
|
9 |
4 |
p. 244-252
9 p.
|
artikel
|
| 22 |
Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?
|
Griffin, Susan
|
|
2006
|
9 |
4 |
p. 244-252
|
artikel
|
| 23 |
Trends in the Measurement of Health Utilities in Published Cost-Utility Analyses
|
Brauer, Carmen A.
|
|
2006
|
9 |
4 |
p. 213-218
6 p.
|
artikel
|
| 24 |
Trends in the Measurement of Health Utilities in Published Cost-Utility Analyses
|
Brauer, Carmen A.
|
|
2006
|
9 |
4 |
p. 213-218
|
artikel
|
Tijdschrift beschrijving